Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human papillomavirus vaccine in a case with ties to U.S. Department of Health and Human Services Secretary Robert F.

A lawyer for the plaintiff in the case said Merck agreed to halting the trial because his team feared that extensive publicity around Kennedy’s Senate confirmation hearings may taint the jury.

President Trump told reporters that tariffs on pharmaceuticals would start at "25% or higher," but did not say when they would start

Merck (NYSE:MRK) and a plaintiff who is suing the drugmaker over allegations that the Gardasil HPV vaccine she received as a teen caused her heart issues and nerve pain have agreed to adjourn the trial.